Comorbid allergic rhinitis and asthma: important clinical considerations

References

• Simons FER. Ancestors of allergy. New York: Global Medical Communications; 1994.
   Google Scholar
• Simons FER. Allergic rhinobronchitis: the asthma–allergic rhinitis link. J Allergy Clin Immunol. 1999;104:534–540.
   PubMed Web of Science ®Google Scholar
• Passalacqua G, Ciprandi G, Canonica GW. United airways disease: therapeutic aspects. Thorax. 2000;55(90002):26S–27.
   Google Scholar
• Amorim MM, Araruna A, Caetano LB, et al. Nasal eosinophilia: an indicator of eosinophilic inflammation in asthma. Clin Exp Allergy. 2010;40:867–874.
   PubMed Web of Science ®Google Scholar
• Irvin CG. The nose: a window into the asthmatic lung? Clin Exp Allergy. 2010;40:839–840.
   PubMedGoogle Scholar
• Ricca V, Landi M, Ferrero P, et al. Minimal persistent inflammation is also present in patients with seasonal allergic rhinitis. J Allergy Clin Immunol. 2000;105:54–57.
   PubMed Web of Science ®Google Scholar
• Ciprandi G, Buscaglia S, Pesce G, et al. Minimal persistent inflammation is present at mucosal level in patients with asymptomatic rhinitis and mite allergy. J Allergy Clin Immunol. 1995;96:971–979.
   PubMed Web of Science ®Google Scholar
• Canonica GW, Compalati E. Minimal persistent inflammation in allergic rhinitis: implications for current treatment strategies. Clin Exp Immunol. 2009;158:260–271.
   PubMedGoogle Scholar
• Bousquet J, van Cauwenberge P, Khaltaev N. Allergic Rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108:S147–S334.
   PubMed Web of Science ®Google Scholar
• Brożek JL, Bousquet J, Baena-Cagnani CE, et al., Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision. J Allergy Clin Immunol. 126(3): 466–476. 2010.
   PubMed Web of Science ®Google Scholar
• Brożek JL, Bousquet J, Agache I, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision. J Allergy Clin Immunol. 2017;140:950–958.
   PubMed Web of Science ®Google Scholar
• Bousquet J, Hellings PW, Agache I, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): change management in allergic rhinitis and asthma multimorbidity using mobile technology. J Allergy Clin Immunol. 2019;143:864–879.
   PubMed Web of Science ®Google Scholar
• Bousquet J, Schünemann HJ, Togias A, et al. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence. J Allergy Clin Immunol. 2020;145:70–80.e3.
   PubMed Web of Science ®Google Scholar
• Tiotiu A, Novakova P, Baiardini I, et al. Manifesto on united airways diseases (UAD): an Interasma (global asthma association – GAA) document. J Asthma. 2021;59(4):639–654.
   PubMedGoogle Scholar
• Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2163–2196.
   PubMed Web of Science ®Google Scholar
• Sullivan SD, Rasouliyan L, Russo PA, et al. Extent, patterns, and burden of uncontrolled disease in severe or difficult-to-treat asthma. Allergy. 2007;62(2):126–133.
   PubMed Web of Science ®Google Scholar
• Sullivan PW, Ghushchyan VH, Slejko JF, et al. The burden of adult asthma in the United States: evidence from the medical expenditure panel survey. J Allergy Clin Immunol. 2011;127:363–369.e3.
   PubMed Web of Science ®Google Scholar
• Chen H, Gould MK, Blanc PD, et al. Asthma control, severity, and quality of life: quantifying the effect of uncontrolled disease. J Allergy Clin Immunol. 2007;120:396–402.
   PubMed Web of Science ®Google Scholar
• Siroux V, Boudier A, Anto JM, et al. Quality-of-life and asthma-severity in general population asthmatics: results of the ECRHS II study. Allergy. 2008;63:547–554.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention; 2022. [cited 2022 May 20]. Available from: www.ginasthma.org.
   Google Scholar
• Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43:343–373.
   PubMed Web of Science ®Google Scholar
• Canonica GW, Baena-Cagnani CE, Blaiss MS, et al. Unmet needs in asthma: global Asthma Physician and Patient (GAPP) Survey: global adult findings. Allergy. 2007;62:668–674.
   PubMed Web of Science ®Google Scholar
• Partridge MR, van der Molen T, Myrseth S-E, et al. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med. 2006;6:13.
   PubMedGoogle Scholar
• Bousquet P-J, Leynaert B, Neukirch F, et al. Geographical distribution of atopic rhinitis in the European community respiratory health survey I. Allergy. 2008;63:1301–1309.
   PubMed Web of Science ®Google Scholar
• Hellgren J, Cervin A, Nordling S, et al. Allergic rhinitis and the common cold - high cost to society. Allergy. 2009;65:776–783.
   PubMedGoogle Scholar
• Devillier P, Bousquet J, Salvator H, et al. In allergic rhinitis, work, classroom and activity impairments are weakly related to other outcome measures. Clin Exp Allergy. 2016;46:1456–1464.
   PubMed Web of Science ®Google Scholar
• Vandenplas O, Vinnikov D, Blanc PD, et al. Impact of rhinitis on work productivity: a systematic review. J Allergy Clin Immunol. 2018;6:1274–1286.e9.
   Google Scholar
• Meltzer EO. Allergic Rhinitis. Immunol Allergy Clin North Am. 2016;36:235–248.
   PubMed Web of Science ®Google Scholar
• Dixon AE, Kaminsky DA, Holbrook JT, et al. Allergic rhinitis and sinusitis in asthma: differential effects on symptoms and pulmonary function. Chest. 2006;130:429–435.
   PubMed Web of Science ®Google Scholar
• Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*. Allergy. 2008;63:8–160.
   PubMed Web of Science ®Google Scholar
• Duffy DL, Martin NG, Battistutta D, et al. Genetics of asthma and hay fever in Australian twins. Amer Rev Respir Dis. 1990;142:1351–1358.
   PubMed Web of Science ®Google Scholar
• Li J, Zhang Y, Zhang L. Discovering susceptibility genes for allergic rhinitis and allergy using a genome-wide association study strategy. Curr Opin Allergy Clin Immunol. 2015;15:33–40.
   PubMedGoogle Scholar
• Lemonnier N, Melén E, Jiang Y, et al. A novel whole blood gene expression signature for asthma, dermatitis, and rhinitis multimorbidity in children and adolescents. Allergy. 2020;75:3248–3260.
   PubMed Web of Science ®Google Scholar
• Wise SK, Lin SY, Toskala E, et al. International consensus statement on allergy and rhinology: allergic Rhinitis. Int Forum Allergy Rhinol. 2018;8:108–352.
   PubMed Web of Science ®Google Scholar
• Okano M, Kariya S, Ohta N, et al. Association and management of eosinophilic inflammation in upper and lower airways. Allergol Int. 2015;64:131–138.
   PubMed Web of Science ®Google Scholar
• Lambrecht BN, Hammad H. Allergens and the airway epithelium response: gateway to allergic sensitization. J Allergy Clin Immunol. 2014;134:499–507.
   PubMed Web of Science ®Google Scholar
• Ebbo M, Crinier A, Vély F, et al. Innate lymphoid cells: major players in inflammatory diseases. Nat Rev Immunol. 2017;17:665–678.
   PubMed Web of Science ®Google Scholar
• Nakayama T, Hirahara K, Onodera A, et al. Th2 cells in health and disease. Annu Rev Immunol. 2017;35:53–84.
   PubMed Web of Science ®Google Scholar
• Coffman RL, Seymour BWP, Hudak S, et al. Antibody to Interleukin-5 Inhibits Helminth-Induced Eosinophilia in Mice. Science (1979). 1989;245:308–310.
   PubMed Web of Science ®Google Scholar
• Kondo Y, Yoshimoto T, Yasuda K, et al. Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. Int Immunol. 2008;20:791–800.
   PubMed Web of Science ®Google Scholar
• Poulsen LK, Hummelshoj L. Triggers of IgE class switching and allergy development. Ann Med. 2007;39:440–456.
   PubMed Web of Science ®Google Scholar
• Palomares Ó, Sánchez-Ramón S, Dávila I, et al. dIvergEnt: how IgE axis contributes to the continuum of allergic asthma and Anti-IgE therapies. Int J Mol Sci. 2017;18:1328.
   Google Scholar
• Di Lorenzo G, Mansueto P, Melluso M, et al. Non-specific airway hyperresponsiveness in mono-sensitive Sicilian patients with allergic rhinitis. Its relationship to total serum IgE levels and blood eosinophils during and out of the pollen season. Clin Exp Allergy. 1997;27:1052–1059.
   PubMed Web of Science ®Google Scholar
• Annesi I, Oryszczyn MP, Neukirch F, et al. Relationship of upper airways disorders to FEV1 and bronchial hyperresponsiveness in an epidemiological study. Eur Respir J. 1992;5:1104–1110.
   PubMedGoogle Scholar
• Helen Ramsdale E, Morris MM, Roberts RS, et al. Asymptomatic bronchial hyperresponsiveness in rhinitis. J Allergy Clin Immunol. 1985;75:573–577.
   PubMedGoogle Scholar
• Iyer A, Athavale A. Nasal airway resistance and latent lower airway involvement in allergic Rhinitis. J Assoc Physicians India. 2020;68:43–47.
   PubMedGoogle Scholar
• Chen M, Ge Y, Lin W, et al. Clinical features and nasal inflammation in asthma and allergic rhinitis. Clin Exp Immunol. 2022;208:25–32.
   Google Scholar
• Marcucci F, Passalacqua G, Canonica GW, et al. Lower airway inflammation before and after house dust mite nasal challenge: an age and allergen exposure-related phenomenon. Respir Med. 2007;101:1600–1608.
   PubMed Web of Science ®Google Scholar
• Crimi E, Milanese M, Oddera S, et al. Inflammatory and mechanical factors of allergen-induced bronchoconstriction in mild asthma and rhinitis. J Appl Physiol. 2001;91:1029–1034.
   PubMed Web of Science ®Google Scholar
• Braunstahl G-J, Kleinjan A, Overbeek SE, et al. Segmental bronchial provocation induces nasal inflammation in allergic Rhinitis patients. Am J Respir Crit Care Med. 2000;161:2051–2057.
   PubMed Web of Science ®Google Scholar
• Chakir J, Laviolette M, Turcotte H, et al. Cytokine expression in the lower airways of nonasthmatic subjects with allergic rhinitis: influence of natural allergen exposure. J Allergy Clin Immunol. 2000;106:904–910.
   PubMed Web of Science ®Google Scholar
• Chakir J, Laviolette M, Boutet M, et al. Lower airways remodeling in nonasthmatic subjects with allergic rhinitis. Lab Invest. 1996;75:735–744.
   PubMed Web of Science ®Google Scholar
• Togias A. Mechanisms of nose-lung interaction. Allergy. 1999;54:94–105.
   PubMed Web of Science ®Google Scholar
• Togias A. Rhinitis and asthma: evidence for respiratory system integration. J Allergy Clin Immunol. 2003;111:1171–1183.
   PubMed Web of Science ®Google Scholar
• Shaaban R, Zureik M, Soussan D, et al. Allergic rhinitis and onset of bronchial hyperresponsiveness. Am J Respir Crit Care Med. 2007;176:659–666.
   PubMedGoogle Scholar
• Boulet L-P, Gauvreau G, Boulay M-E, et al. Allergen-induced early and late asthmatic responses to inhaled seasonal and perennial allergens. Clin Exp Allergy. 2015;45:1647–1653.
   PubMedGoogle Scholar
• Zureik M, Neukirch C, Leynaert B, et al. Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health survey. BMJ. 2002;325:411–414.
   PubMed Web of Science ®Google Scholar
• Targonski P, Persky V, Ramekrishnan V. Effect of environmental molds on risk of death from asthma during the pollen season. J Allergy Clin Immunol. 1995;95:955–961.
   PubMed Web of Science ®Google Scholar
• Black PN, Udy AA, Brodie SM. Sensitivity to fungal allergens is a risk factor for life-threatening asthma. Allergy. 2000;55:501–504.
   PubMed Web of Science ®Google Scholar
• O’Hollaren MT, Yunginger JW, Offord KP, et al. Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma. N Engl J Med. 1991;324:359–363.
   PubMed Web of Science ®Google Scholar
• Sarpong SB, Karrison T. Skin test reactivity to indoor allergens as a marker of asthma severity in children with asthma. Ann Allergy Asthma Immunol. 1998;80:303–308.
   PubMed Web of Science ®Google Scholar
• Li J, Huang Y, Lin X, et al. Influence of degree of specific allergic sensitivity on severity of rhinitis and asthma in Chinese allergic patients. Respir Res. 2011;12:95.
   PubMed Web of Science ®Google Scholar
• Shaaban R, Zureik M, Soussan D, et al. Rhinitis and onset of asthma: a longitudinal population-based study. Lancet. 2008;372:1049–1057.
   PubMed Web of Science ®Google Scholar
• Sears MR, Greene JM, Willan AR, et al. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med. 2003;349(15):1414–1422.
   PubMed Web of Science ®Google Scholar
• Polosa R, Al-Delaimy WK, Russo C, et al. Greater risk of incident asthma cases in adults with allergic Rhinitis and effect of allergen immunotherapy: a retrospective cohort study. Respir Res. 2005;6(1):153.
   PubMedGoogle Scholar
• Jiménez-Feijoo R, Pascal M, Moya R, et al. Molecular diagnosis in house dust mite – allergic patients suggests That Der p 23 is clinically relevant in asthmatic children. J Investig Allergol Clin Immunol. 2020;30:127–132.
   PubMedGoogle Scholar
• Celi G, Brusca I, Scala E, et al. House dust mite allergy in Italy—Diagnostic and clinical relevance of Der p 23 (and of minor allergens): a real‐life, multicenter study. Allergy. 2019;74:1787–1789.
   PubMedGoogle Scholar
• Melioli G, Canonica GW. Molecular allergy diagnosis: we need to become more knowledgeable. Ann Allergy Asthma Immunol. 2012;108:387.
   PubMed Web of Science ®Google Scholar
• Caimmi D, Manca E, Carboni E, et al. How molecular allergology can shape the management of allergic airways diseases. Curr Opin Allergy Clin Immunol. 2020;20:149–154.
   PubMedGoogle Scholar
• Rochat MK, Illi S, Ege MJ, et al. Allergic rhinitis as a predictor for wheezing onset in school-aged children. J Allergy Clin Immunol. 2010;126:1170–5.e2.
   PubMedGoogle Scholar
• Tohidinik HR, Mallah N, Takkouche B. History of allergic rhinitis and risk of asthma; a systematic review and meta-analysis. World Allergy Organ J. 2019;12:100069.
   PubMed Web of Science ®Google Scholar
• Plaschke PP, Janson C, Norrman E, et al. Onset and remission of allergic rhinitis and asthma and the relationship with atopic sensitization and smoking. Am J Respir Crit Care Med. 2000;162:920–924.
   PubMed Web of Science ®Google Scholar
• Lombardi C, Passalacqua G, Gargioni S, et al. The natural history of respiratory allergy: a follow-up study of 99 patients up to 10 years. Respir Med. 2001;95:9–12.
   PubMed Web of Science ®Google Scholar
• Wahn PU. Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomised, placebo-controlled trial: first results of ETA®. Pediatr Allergy Immunol. 1998;9:116–124.
   PubMedGoogle Scholar
• Jacobsen L, Niggemann B, Dreborg S, et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy. 2007;62:943–948.
   PubMed Web of Science ®Google Scholar
• Holgate ST, Wenzel S, Postma DS, et al. Asthma. Nat Rev Dis Primers. 2015;1:15025.
   PubMed Web of Science ®Google Scholar
• Burgess JA, Walters EH, Byrnes GB, et al. Childhood allergic rhinitis predicts asthma incidence and persistence to middle age: a longitudinal study. J Allergy Clin Immunol. 2007;120:863–869.
   PubMed Web of Science ®Google Scholar
• Price D, Zhang Q, Kocevar VS, et al. Effect of a concomitant diagnosis of allergic rhinitis on asthma-related health care use by adults. Clin Exp Allergy. 2005;35:282–287.
   PubMed Web of Science ®Google Scholar
• Thomas M, Kocevar VS, Zhang Q, et al. Asthma-related health care resource use among asthmatic children with and without concomitant allergic Rhinitis. Pediatrics. 2005;115:129–134.
   PubMed Web of Science ®Google Scholar
• Sazonov Kocevar V, Thomas J, Jonsson L, et al. Association between allergic rhinitis and hospital resource use among asthmatic children in Norway. Allergy. 2005;60:338–342.
   PubMed Web of Science ®Google Scholar
• Bousquet J, Gaugris S, Kocevar VS, et al. Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: a subgroup analysis of the improving asthma control trial. Clin Exp Allergy. 2005;35:723–727.
   PubMed Web of Science ®Google Scholar
• Ponte EV, Franco R, Nascimento HF, et al. Lack of control of severe asthma is associated with co-existence of moderate-to-severe rhinitis. Allergy. 2008;63:564–569.
   PubMed Web of Science ®Google Scholar
• Braido F, Baiardini I, Balestracci S, et al. Does asthma control correlate with quality of life related to upper and lower airways? A real life study. Allergy. 2009;64(6):937–943.
   PubMedGoogle Scholar
• Lin J, Gao J, Lai K, et al. The characteristic of asthma control among nasal diseases population: results from a cross-sectional study. PLOS ONE. 2018;13(2):e0191543.
   PubMed Web of Science ®Google Scholar
• Thomas M. Allergic rhinitis: evidence for impact on asthma. BMC Pulm Med. 2006;6:S4.
   PubMedGoogle Scholar
• Pasquali M, Baiardini I, Rogkakou A, et al. Levocetirizine in persistent allergic rhinitis and asthma: effects on symptoms, quality of life and inflammatory parameters. Clin Exp Allergy. 2006;36:1161–1167.
   PubMed Web of Science ®Google Scholar
• Baena-Cagnani CE. Desloratadine activity in concurrent seasonal allergic rhinitis and asthma. Allergy. 2001;56(Suppl 65):21–27.
   PubMed Web of Science ®Google Scholar
• Grant JA, Nicodemus CF, Findlay SR, et al. Cetirizine in patients with seasonal rhinitis and concomitant asthma: prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol. 1995;95:923–932.
   PubMed Web of Science ®Google Scholar
• Simons FE. Is antihistamine (H1-receptor antagonist) therapy useful in clinical asthma? Clin Exp Allergy. 1999;29(Suppl 3):98–104.
   PubMed Web of Science ®Google Scholar
• Egan M, Bunyavanich S. Allergic rhinitis: the “Ghost Diagnosis” in patients with asthma. Asthma Res Pract. 2015;1:8.
   PubMedGoogle Scholar
• Adams RJ, Fuhlbrigge AL, Finkelstein JA, et al. Intranasal steroids and the risk of emergency department visits for asthma. J Allergy Clin Immunol. 2002;109:636–642.
   PubMed Web of Science ®Google Scholar
• Crystal-Peters J, Neslusan C, Crown WH, et al. Treating allergic rhinitis in patients with comorbid asthma: the risk of asthma-related hospitalizations and emergency department visits. J Allergy Clin Immunol. 2002;109:57–62.
   PubMed Web of Science ®Google Scholar
• Corren J, Manning BE, Thompson SF, et al. Rhinitis therapy and the prevention of hospital care for asthma. J Allergy Clin Immunol. 2004;113:415–419.
   PubMed Web of Science ®Google Scholar
• Bousquet J, Anto JM, Bachert C, et al. Allergic rhinitis. Nat Rev Dis Primers. 2020;6:95.
   PubMed Web of Science ®Google Scholar
• Bousquet J, Schünemann HJ, Hellings PW, et al. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis. J Allergy Clin Immunol. 2016;138(2):367–374.e2.
   PubMed Web of Science ®Google Scholar
• Menditto E, Costa E, Midão L, et al. Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study. Clin Exp Allergy. 2019;49:442–460.
   PubMed Web of Science ®Google Scholar
• Bédard A, Basagaña X, Anto JM, et al. Mobile technology offers novel insights into the control and treatment of allergic rhinitis: the MASK study. J Allergy Clin Immunol. 2019;144:135–143.e6.
   PubMed Web of Science ®Google Scholar
• Murphy J, McSharry J, Hynes L, et al. Prevalence and predictors of adherence to inhaled corticosteroids in young adults (15–30 years) with asthma: a systematic review and meta-analysis. J Asthma. 2021;58:683–705.
   PubMedGoogle Scholar
• Persaud YK. Using telemedicine to care for the asthma patient. Curr Allergy Asthma Rep. 2022;22:43–52.
   PubMed Web of Science ®Google Scholar
• Chan AHY, Foot H, Pearce CJ, et al. Effect of electronic adherence monitoring on adherence and outcomes in chronic conditions: a systematic review and meta-analysis. PLOS ONE. 2022;17:e0265715.
   PubMedGoogle Scholar
• Perry TT, Marshall A, Berlinski A, et al. Smartphone-based vs paper-based asthma action plans for adolescents. Ann Allergy Asthma Immunol. 2017;118:298–303.
   PubMedGoogle Scholar
• Johnson KB, Patterson BL, Y-X H, et al. The feasibility of text reminders to improve medication adherence in adolescents with asthma. J Am Med Inf Assoc. 2016;23:449–455.
   PubMed Web of Science ®Google Scholar
• Cingi C, Yorgancioglu A, Cingi CC, et al. The “physician on call patient engagement trial” (POPET): measuring the impact of a mobile patient engagement application on health outcomes and quality of life in allergic rhinitis and asthma patients. Int Forum Allergy Rhinol. 2015;5:487–497.
   PubMed Web of Science ®Google Scholar
• Hui CY, Walton R, McKinstry B, et al. The use of mobile applications to support self-management for people with asthma: a systematic review of controlled studies to identify features associated with clinical effectiveness and adherence. J Am Med Inf Assoc. 2017;24:619–632.
   PubMed Web of Science ®Google Scholar
• Cook KA, Modena BD, Simon RA. Improvement in asthma control using a minimally burdensome and proactive smartphone application. J Allergy Clin Immunol. 2016;4:730–737.e1.
   Google Scholar
• Bousquet JJ, Schünemann HJ, Togias A, et al. Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases. Clin Transl Allergy. 2019;9:44.
   PubMed Web of Science ®Google Scholar
• Bosnic‐Anticevich S, Costa E, Menditto E, et al. ARIA pharmacy 2018 allergic rhinitis care pathways for community pharmacy. Allergy. 2019:all.13701. DOI:https://doi.org/10.1111/all.13701
   Google Scholar
• Wu EL, Harris WC, Babcock CM, et al. Epistaxis risk associated with intranasal corticosteroid sprays: a systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2019;161:18–27.
   PubMed Web of Science ®Google Scholar
• Patel P, Roland PS, Marple BF, et al. An assessment of the onset and duration of action of olopatadine nasal spray. Otolaryngol Head Neck Surg. 2007;137:918–924.
   PubMed Web of Science ®Google Scholar
• Horak F, Petra Zieglmayer U, Zieglmayer R, et al. Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy. Curr Med Res Opin. 2006;22:151–157.
   PubMed Web of Science ®Google Scholar
• Patel P, D’Andrea C, Sacks HJ. Onset of action of azelastine nasal spray compared with mometasone nasal spray and placebo in subjects with seasonal allergic Rhinitis evaluated in an environmental exposure chamber. Am J Rhinol. 2007;21:499–503.
   PubMedGoogle Scholar
• Bousquet J, Meltzer EO, Couroux P, et al. Onset of action of the fixed combination intranasal azelastine-fluticasone propionate in an allergen exposure chamber. J Allergy Clin Immunol Pract. 2018;6(5):1726–1732.e6.
   PubMed Web of Science ®Google Scholar
• Patel P, Patel D, Kunjibettu S, et al. Onset of action of ciclesonide once daily in the treatment of seasonal allergic rhinitis. Ear Nose Throat J. 2008;87:340–353.
   PubMedGoogle Scholar
• Wallace DV, Dykewicz MS, Oppenheimer J, et al. Pharmacologic treatment of seasonal allergic Rhinitis: synopsis of Guidance From the 2017 joint task force on practice parameters. Ann Intern Med. 2017;167:876.
   PubMed Web of Science ®Google Scholar
• Patel P, Salapatek AM, Tantry SK. Effect of olopatadine-mometasone combination nasal spray on seasonal allergic rhinitis symptoms in an environmental exposure chamber study. Ann Allergy Asthma Immunol. 2019;122(2):160–166.e1.
   PubMedGoogle Scholar
• Andrews CP, Mohar D, Salhi Y, et al. Efficacy and safety of twice-daily and once-daily olopatadine-mometasone combination nasal spray for seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2020;124(2):171–178.e2.
   PubMed Web of Science ®Google Scholar
• Gross GN, Berman G, Amar NJ, et al. Efficacy and safety of olopatadine-mometasone combination nasal spray for the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2019;122:630–638.e3.
   PubMed Web of Science ®Google Scholar
• Antonijoan R, Coimbra J, García-Gea C, et al. Comparative efficacy of bilastine, desloratadine and rupatadine in the suppression of wheal and flare response induced by intradermal histamine in healthy volunteers. Curr Med Res Opin. 2017;33:129–136.
   PubMed Web of Science ®Google Scholar
• Barnes ML, Menzies D, Fardon TC, et al. Combined mediator blockade or topical steroid for treating the unified allergic airway. Allergy. 2007;62:73–80.
   PubMed Web of Science ®Google Scholar
• Dixon EG, Rugg-Gunn CE, Sellick V, et al. Adverse drug reactions of leukotriene receptor antagonists in children with asthma: a systematic review. BMJ Paediatr Open. 2021;5:e001206.
   PubMedGoogle Scholar
• Hox V, Lourijsen E, Jordens A, et al. Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper. Clin Transl Allergy. 2020;10(1):1.
   PubMedGoogle Scholar
• Akdis CA, Akdis M. Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens. World Allergy Organ J. 2015;8:17.
   PubMed Web of Science ®Google Scholar
• Bousquet J, Pfaar O, Togias A, et al. 2019 ARIA Care pathways for allergen immunotherapy. Allergy. 2019;74(11):2087–2102.
   PubMed Web of Science ®Google Scholar
• Tabar AI, Delgado J, González-Mancebo E, et al., Recent advances in allergen-specific immunotherapy as treatment for allergic asthma: a practical overview. Int Arch Allergy Immunol. 182(6): 496–514. 2021.
   PubMedGoogle Scholar
• Shamji MH, Kappen J, Abubakar-Waziri H, et al. Nasal allergen-neutralizing IgG4 antibodies block IgE-mediated responses: novel biomarker of subcutaneous grass pollen immunotherapy. J Allergy Clin Immunol. 2019;143(3):1067–1076.
   PubMed Web of Science ®Google Scholar
• Shamji MH, Larson D, Eifan A, et al. Differential induction of allergen-specific IgA responses following timothy grass subcutaneous and sublingual immunotherapy. J Allergy Clin Immunol. 2021;148:1061–1071.e11.
   PubMedGoogle Scholar
• Shamji MH, Sharif H, Layhadi JA, et al. Diverse immune mechanisms of allergen immunotherapy for allergic rhinitis with and without asthma. J Allergy Clin Immunol. 2022;149:791–801.
   PubMedGoogle Scholar
• Shamji MH, Layhadi JA, Scadding GW, et al. Basophil expression of diamine oxidase: a novel biomarker of allergen immunotherapy response. J Allergy Clin Immunol. 2015;135:913–921.e9.
   PubMed Web of Science ®Google Scholar
• Eljaszewicz A, Ruchti F, Radzikowska U, et al. Trained immunity and tolerance in innate lymphoid cells, monocytes, and dendritic cells during allergen-specific immunotherapy. J Allergy Clin Immunol. 2021;147(5):1865–1877.
   PubMed Web of Science ®Google Scholar
• Pilette C, Nouri-Aria KT, Jacobson MR, et al. Grass pollen immunotherapy induces an allergen-specific IgA2 antibody response associated with mucosal TGF-β expression. J Immunol. 2007;178(7):4658–4666.
   PubMed Web of Science ®Google Scholar
• Nouri-Aria KT, Wachholz PA, Francis JN, et al. Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity. J Immunol. 2004;172(5):3252–3259.
   PubMed Web of Science ®Google Scholar
• Scadding GW, Eifan AO, Lao‐Araya M, et al. Effect of grass pollen immunotherapy on clinical and local immune response to nasal allergen challenge. Allergy. 2015;70(6):689–696.
   PubMed Web of Science ®Google Scholar
• Sharif H, Acharya S, Dhondalay GKR, et al. Altered chromatin landscape in circulating T follicular helper and regulatory cells following grass pollen subcutaneous and sublingual immunotherapy. J Allergy Clin Immunol. 2021;147(2):663–676.
   PubMedGoogle Scholar
• Scadding GW, Calderon MA, Shamji MH, et al. Effect of 2 years of treatment with sublingual grass pollen immunotherapy on nasal response to allergen challenge at 3 years among patients with moderate to severe seasonal allergic Rhinitis. JAMA. 2017;317(6):615.
   PubMed Web of Science ®Google Scholar
• Golebski K, Layhadi JA, Sahiner U, et al. Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response. Immunity. 2021;54(2):291–307.e7.
   PubMed Web of Science ®Google Scholar
• Shamji MH, Layhadi JA, Sharif H, et al. Immunological responses and biomarkers for allergen-specific immunotherapy against inhaled allergens. J Allergy Clin Immunol. 2021;9:1769–1778.
   Google Scholar
• Möbs C, Slotosch C, Löffler H, et al. Birch pollen immunotherapy leads to differential induction of Regulatory T Cells and delayed Helper T Cell immune deviation. J Immunol. 2010;184(4):2194–2203.
   PubMed Web of Science ®Google Scholar
• Durham SR, Ying S, Varney VA, et al. Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-γ. J Allergy Clin Immunol. 1996;97:1356–1365.
   PubMed Web of Science ®Google Scholar
• Gradman J, Halken S. Preventive effect of allergen immunotherapy on asthma and new sensitizations. J Allergy Clin Immunol. 2021;9:1813–1817.
   Google Scholar
• Morjaria JB, Caruso M, Emma R, et al. Treatment of allergic rhinitis as a strategy for preventing asthma. Curr Allergy Asthma Rep. 2018;18:23.
   PubMed Web of Science ®Google Scholar
• Abramson MJ, Puy RM, Weiner JM. Injection allergen immunotherapy for asthma. Cochrane Database Syst Rev. 2010. DOI:https://doi.org/10.1002/14651858.CD001186.pub2
   Google Scholar
• Kristiansen M, Dhami S, Netuveli G, et al. Allergen immunotherapy for the prevention of allergy: a systematic review and meta-analysis. Pediatr Allergy Immunol. 2017;28:18–29.
   PubMed Web of Science ®Google Scholar
• Alvaro‐Lozano M, Akdis CA, Akdis M, et al. Allergen immunotherapy in children user’s guide. Pediatr Allergy Immunol. 2020;31:1–101.
   PubMedGoogle Scholar
• Agache I, Lau S, Akdis CA, et al. EAACI guidelines on allergen immunotherapy: house dust mite‐driven allergic asthma. Allergy. 2019;74:855–873.
   PubMed Web of Science ®Google Scholar
• Compalati E, Incorvaia C, Cavaliere C, et al. The role of allergoids in allergen immunotherapy: from injective to sublingual route. Eur Ann Allergy Clin Immunol. 2020;52:195.
   PubMed Web of Science ®Google Scholar
• Gupta K, Kumar S, Das M, et al. Peptide based immunotherapy: a pivotal tool for allergy treatment. Int Immunopharmacol. 2014;19:391–398.
   PubMedGoogle Scholar
• Yu C, Wang K, Cui X, et al. Clinical efficacy and safety of omalizumab in the treatment of allergic Rhinitis: a systematic review and meta-analysis of randomized clinical trials. Am J Rhinol Allergy. 2020;34:196–208.
   PubMed Web of Science ®Google Scholar
• Weinstein SF, Katial R, Jayawardena S, et al. Efficacy and safety of dupilumab in perennial allergic rhinitis and comorbid asthma. J Allergy Clin Immunol. 2018;142:171–177.e1.
   PubMed Web of Science ®Google Scholar
• Gibson PG, Prazma CM, Chupp GL, et al. Mepolizumab improves clinical outcomes in patients with severe asthma and comorbid conditions. Respir Res. 2021;22:171.
   PubMed Web of Science ®Google Scholar